Did You Catch Axios' Recent Headlines About the Boulder Terror Attack? Who's Running...
CNN's Panel on Antisemitism Was a Total Trainwreck
Reporter Gave a Laughable Reason for Why We Can't Trust Polls Now
I'm Not So Sure Bill Clinton Is the Person to Lead Point on...
CBS News' Margaret Brennan Got Wrecked By Scott Bessent and Marty Makary Over...
Watch Scott Jennings Obliterate a Reporter Over Her 'Both Sides' Nonsense on Political...
Here's What You Should Know About Mohamad Soliman
Jewish Americans Can No Longer Afford to Be Unarmed
Sanctuary States, Sleeper Cells, and a Nation on the Brink
Supreme Court Takes Up Key Election Law Case
White House Shuts Down One of the 'Most Disgusting Lies' Being Spread About...
Hey You, Get Off My Crowd
Two People Rescued After Plane Crashes Off the Coast of Connecticut
Marco Rubio Has a Warning for 'All Terrorists'
This Transgender Athlete Shared This Flippant Response After Dominating a Women's Race
Tipsheet

Florida Surgeon General Accuses Biden Administration of 'Actively Preventing' One Important Covid-19 Treatment

AP Photo/Rich Pedroncelli, File

In a letter to Health and Human Services Secretary Xavier Becerra, Florida’s surgeon general Joseph Ladapo accused the Biden administration of “actively preventing” the distribution of a life-saving Covid-19 treatment.

Advertisement

Ladapo detailed how Florida was ahead of the curve in using monoclonal antibodies, explaining that by mid-September, nearly 100,000 patients received this life-saving treatment.

“Shortly after Florida’s 100,000 treatment milestone, and without any advanced notice, the U.S. Department of Health and Human Services (HHS) announced a dramatic reduction in the number of monoclonal antibodies to be allocated to the State of Florida,” Ladapo said. “Governor DeSantis moved quickly to acquire Sotrovimab from GlaxoSmithKline to help alleviate the artificial shortage caused by this sudden shift from HHS. However, the lack of allocation of this life-saving treatment from the federal government continues to cause another immediate and life-threatening shortage of treatment options” amid the spread of Omicron. 

Ladapo recognized the evidence that some treatment options may not be as effective for Omicron as Delta, but still argued that federal agencies shouldn’t limit any treatment options, as providers are still caring for Covid-19 patients in areas with a low prevalence of the new variant.

“The federal government is actively preventing the effective distribution of monoclonal antibody treatments in the U.S. The sudden suspension of multiple monoclonal antibody therapy treatments from distribution to Florida removes a health care provider’s ability to decide the best treatment options for their patients in this state,” he said. “This shortsightedness is especially evident given that the federal government effectively prohibited states from purchasing these monoclonal antibodies and serving their populations directly.”

Advertisement

Ladapo concluded by reminding Becerra that President Biden recently acknowledged “there is no federal solution” to the pandemic, but that it “gets solved at the state level.” He requested the federal government not hinder Florida’s ability to provide treatment options.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement